DK0419387T3 - Hidtil ukendte hydrofile derivater, terapeutisk og diagnostisk anvendelse, diagnostiske eller terapeutiske kit og immunologiske reagenser - Google Patents

Hidtil ukendte hydrofile derivater, terapeutisk og diagnostisk anvendelse, diagnostiske eller terapeutiske kit og immunologiske reagenser

Info

Publication number
DK0419387T3
DK0419387T3 DK90430018.3T DK90430018T DK0419387T3 DK 0419387 T3 DK0419387 T3 DK 0419387T3 DK 90430018 T DK90430018 T DK 90430018T DK 0419387 T3 DK0419387 T3 DK 0419387T3
Authority
DK
Denmark
Prior art keywords
therapeutic
diagnostic
immunological reagents
kits
hydrophilic derivatives
Prior art date
Application number
DK90430018.3T
Other languages
English (en)
Inventor
Jean-Marc Le Doussal
Jacques Barbet
Michel Delaage
Anne Gruaz-Guyon
Original Assignee
Immunotech Partners Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Partners Sa filed Critical Immunotech Partners Sa
Application granted granted Critical
Publication of DK0419387T3 publication Critical patent/DK0419387T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90430018.3T 1989-09-21 1990-09-20 Hidtil ukendte hydrofile derivater, terapeutisk og diagnostisk anvendelse, diagnostiske eller terapeutiske kit og immunologiske reagenser DK0419387T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8912622A FR2652004B1 (fr) 1989-09-21 1989-09-21 Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques.

Publications (1)

Publication Number Publication Date
DK0419387T3 true DK0419387T3 (da) 1997-04-07

Family

ID=9385847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90430018.3T DK0419387T3 (da) 1989-09-21 1990-09-20 Hidtil ukendte hydrofile derivater, terapeutisk og diagnostisk anvendelse, diagnostiske eller terapeutiske kit og immunologiske reagenser

Country Status (11)

Country Link
US (1) US5274076A (da)
EP (1) EP0419387B1 (da)
JP (1) JP2914737B2 (da)
KR (1) KR0166075B1 (da)
AT (1) ATE145338T1 (da)
AU (1) AU638488B2 (da)
CA (1) CA2025607C (da)
DE (1) DE69029184T2 (da)
DK (1) DK0419387T3 (da)
ES (1) ES2094750T3 (da)
FR (1) FR2652004B1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118120A1 (de) * 1991-06-03 1992-12-10 Behringwerke Ag Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
WO1993003351A1 (en) * 1991-08-09 1993-02-18 The Regents Of The University Of California Amino acid, ester and/or catechol contrast agents for mri
US5562894A (en) * 1991-08-09 1996-10-08 Regents Of The University Of California Amino-acyl-type and catecholamine-type contrast agents for MRI
US6096289A (en) 1992-05-06 2000-08-01 Immunomedics, Inc. Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy
CA2094785A1 (en) * 1992-05-08 1993-11-09 Jean Gariepy Metal chelating peptide
US6228362B1 (en) 1992-08-21 2001-05-08 Immunomedics, Inc. Boron neutron capture therapy using pre-targeting methods
FR2697255B1 (fr) * 1992-10-27 1995-01-13 Immunotech Partners Nouveaux dérivés bihaptènes liant le technétium, application au diagnostic et à la thérapeutique, kits et réactifs immunologiques les mettant en Óoeuvre.
DE4428874A1 (de) * 1994-08-08 1996-02-22 Schering Ag Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
DE19533477C2 (de) * 1995-09-12 1997-10-23 Pharma Beratung Dr Klaus Hoffm Verwendung von Diethylentriaminpentaessigsäure (DTPA) mit immunsuppressiver Wirkung
US6663866B1 (en) 1996-08-28 2003-12-16 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis
US6558669B1 (en) * 1996-08-28 2003-05-06 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis
AU718859B2 (en) * 1996-08-28 2000-04-20 Immunomedics Inc. Stable radioiodine conjugates and methods for their synthesis
US20040096394A1 (en) * 1996-08-28 2004-05-20 Immunomedics, Inc. Stable radioiodine conjugates and methods for their systhesis
US7521531B2 (en) * 1996-08-28 2009-04-21 Immunomedics, Inc. Methods for the purification of stable radioiodine conjugates
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
AU740563B2 (en) * 1998-05-07 2001-11-08 Immunomedics Inc. Positron emission tomography using gallium-68 chelates
US6071490A (en) * 1998-05-07 2000-06-06 Immunomedics, Inc. Position emission tomography using gallium-68 chelates
US7074405B1 (en) 1998-06-22 2006-07-11 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US6962702B2 (en) 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7833528B2 (en) * 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
US7387772B1 (en) * 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
US7052872B1 (en) 1999-06-22 2006-05-30 Immunomedics, Inc. Bi-specific antibodies for pre-targeting diagnosis and therapy
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
FR2816620B1 (fr) * 2000-11-16 2003-02-21 Inst Nat Sante Rech Med Nouveaux composes pour des applications a la radioimmunoscintingraphie et/ou a la radioimmunotherapie des cancers
EP1411987A2 (en) * 2001-07-31 2004-04-28 Immunomedics, Inc. Targeted polymeric delivery systems
WO2003048207A2 (en) * 2001-11-28 2003-06-12 Immunomedics, Inc. Anti-dota antibody
JP4937751B2 (ja) * 2003-06-13 2012-05-23 イミューノメディクス、インコーポレイテッド Ｄ−アミノ酸ペプチド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2437398A1 (fr) * 1978-06-20 1980-04-25 Commissariat Energie Atomique Compose iode utilisable comme traceur en radio-immunologie
CA1213229A (en) * 1982-04-12 1986-10-28 Gary S. David Antibodies having dual specificities, their preparation and uses therefor
US4479930A (en) * 1982-07-26 1984-10-30 Trustees Of The University Of Massachusetts Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
CA1282069C (en) * 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
ES2058492T3 (es) * 1988-02-03 1994-11-01 Hybritech Inc Mejoras en o relativas a haptenos modificados utiles como agentes terapeuticos y de formacion de imagenes.
AU3069489A (en) * 1988-02-08 1989-08-25 Cytogen Corporation Novel and improved antibodies for site specific attachment of compounds

Also Published As

Publication number Publication date
DE69029184T2 (de) 1997-06-05
FR2652004A1 (fr) 1991-03-22
ATE145338T1 (de) 1996-12-15
DE69029184D1 (de) 1997-01-02
JP2914737B2 (ja) 1999-07-05
KR0166075B1 (ko) 1999-01-15
JPH03173900A (ja) 1991-07-29
AU638488B2 (en) 1993-07-01
US5274076A (en) 1993-12-28
KR910005862A (ko) 1991-04-27
CA2025607A1 (en) 1991-03-22
AU6303490A (en) 1991-03-28
EP0419387A1 (fr) 1991-03-27
CA2025607C (en) 2001-08-07
FR2652004B1 (fr) 1994-10-28
EP0419387B1 (fr) 1996-11-20
ES2094750T3 (es) 1997-02-01

Similar Documents

Publication Publication Date Title
AU638488B2 (en) Novel hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents
FI895959A7 (fi) Koostumus, diagnostinen käyttöpakkaus ja menetelmä vasta-aineiden nope aksi toteamiseksi
Nopparatana et al. Purification of Gnathostoma spinigerum specific antigen and immunodiagnosis of human gnathostomiasis
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
DE3575789D1 (de) Gleichseitige mehrfache proben und in denselben zu verwendende zusammensetzungen.
KR870003195A (ko) 단일클론 항체를 이용한 그램 네가티브 박테리아 감염증의 검진 방법
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
RU94046284A (ru) Способ обнаружения антител, способ с-крекинга компонентов крови, набор для обнаружения антител к hcv
BR8300656A (pt) Ensaio para determinar a concentracao de antigenos, processo para determinar o periodo fertil do ciclo menstrual, conjunto de reagente, e molecula ligante
NO169243C (no) Monoklonalt antistoff, hybridcellelinje og anvendelse av det monoklonale antistoffet for analyse av leukocytt-populasjonen i en proeve av humant perifert blod
SE8701905D0 (sv) A method and a kit for the diagnosis of iga nephropathy
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
Turner et al. Simple method of subtyping human G-myeloma proteins based on sensitivity to pepsin digestion
DE69713146D1 (de) Helicobacter pylori diagnostika
BE883905A (fr) Tests et reactifs de diagnostic par agglutination
DE3650635D1 (de) Monoklonale Antikörper
FI905350A7 (fi) Leimattua streptokokki-vasta-ainetta sisältävä koostumus, testipakkaus ja analyysimenetelmä, jossa sitä käytetään
SU1425549A1 (ru) Способ радиоиммунологического определени антигенов
FI102115B1 (fi) Diagnostiikassa käytettävä monoklonaalinen vasta-ainekoostumus ja sitä sisältävä testipakkaus
KR910017189A (ko) 암의 혈청진단법 및 이에 사용되는 키트(kit)